Antileishmania antibodies and functional activity of complement components in patients with visceral leishmaniasis in Kenya.
D000906:Antibodies / Q000032:analysis*; D003171:Complement Pathway, Classical; D003165:Complement System Proteins / Q000032:analysis*; D003298:Coombs Test; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007630:Kenya; D007891:Leishmania / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000453:epidemiology / Q000276:immunology*
D000906:Antibodies; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D003165:Complement System Proteins